Author:
van Gestel Yvette R. B. M.,Lemmens Valery E. P. P.,de Hingh Ignace H. J. T.,Steevens Jessie,Rutten Harm J. T.,Nieuwenhuijzen Grard A. P.,van Dam Ronald M.,Siersema Peter D.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Milosavljevic T, Kostic-Milosavljevic M, Jovanovic I, Krstic M. Gastrointestinal and liver tumours and public health in Europe. Eur Rev Med Pharmacol Sci. 2010;14:259–62.
2. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL, Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441–7.
3. Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996. J Clin Epidemiol. 1999;52:1131–6.
4. Gonzalez EC, Ferrante JM, Van Durme DJ, Pal N, Roetzheim RG. Comorbid illness and the early detection of cancer. South Med J. 2001;94:913–20.
5. Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006-a population-based cohort study. Dis Colon Rectum. 2009;52:71–8.
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献